Research Opportunities
The Yale AIDS program continues to welcome research projects that are beneficial for patients, science and medicine, from:
- basic research (Elite controllers, mitochondrial dysfunction, cellular changes with aging, etc.) to
- clinical research (HIV and Alcohol, Transition of inmate to primary care, Timing of ART initiation, etc.) to
- clinical trials (No Nukes, New ART agents, Genotype testing, etc.).
The resident will be encouraged to develop, conduct and present a research project by the end of the third year.
Other Residency Research Opportunities
Recent Publications
See recent publications by our faculty.
Publications
- Who feels safe calling 911: are prior experiences of anti-Black racial discrimination associated with hesitancy seeking emergency medical services in the event of accidental drug overdose? - a study protocol.Hall OT, Trimble C, Garcia S, Grayson S, Joseph L, Entrup P, Jegede O, Martel JP, Tetrault J, Mathis M, Jordan A. Ann Med. 2025 Dec; 2024 Dec 19. PMID: 39697058.
- Loneliness among refugees: a neglected crisis in need of scalable innovation.Liu S, Bromberg DJ, Haucke M, Zhou X, Poole D, Bärnighausen T, Altice FL. Lancet Reg Health Eur. 2025 Jul; 2025 Jun 17. PMID: 40599742.
- The viral playbook threatening the National Institutes of Health: a call to inoculate the immune system of American science.Altice FL. Lancet Reg Health Am. 2025 Jul; 2025 Jun 11. PMID: 40546883.
- Alcohol Use and the Pre-exposure Prophylaxis Continuum of Care Among Men in Rural South Africa: Results from a Longitudinal Study.Castle AC, Busang J, Dreyer J, Herbst C, Okesola N, Chimbindi N, Zuma T, Jarolimova J, Hahn JA, Psaros C, Shenoi SV, Shahmanesh M, Siedner MJ. AIDS Behav. 2025 Jul; 2025 Apr 5. PMID: 40185960.
- Medications for opioid use disorder shape immune responses during chronic HIV infection.Collora JA, Steinhauser SF, Davenport TC, Lin DC, Eshetu A, Zeidi S, Kim R, Frank C, Kluger Y, Springer SA, Ho YC. Cell Rep Med. 2025 Jun 17; 2025 Jun 2. PMID: 40460829.
- Information Needs for Opioid Use Disorder Treatment Using Buprenorphine Product: Qualitative Analysis of Suboxone-Focused Reddit Data.Basak M, Sharif O, Lord SE, Borodovsky JT, Marsch LA, Springer SA, Nunes EV, Brackett CD, Archibald LJ, Preum SM. J Med Internet Res. 2025 Jun 9; 2025 Jun 9. PMID: 40489766.
- A qualitative examination of barriers and facilitators to HIV prevention and treatment for people involved with the criminal justice system.Villaire S, Sease T, Pankow J, Bennett A, Pulitzer Z, Hansen L, Frank C, Di Paola A, Lehman W, Sanchez M, McQuaid A, Schultheis A, Stein B, Springer SA, Nijhawan AE, Knight K. Health Justice. 2025 Jun 6; 2025 Jun 6. PMID: 40478391.
- Ibalizumab plus an optimized background regimen in treatment-experienced patients infected with multidrug resistant HIV-1: A phase 3, multicenter, expanded access study.Emu B, Kumar PN, Mills A, Berhe M, Cash BR, Kuo KL, Anstett K. J Acquir Immune Defic Syndr. 2025 Jun 4; 2025 Jun 4. PMID: 40465394.
- Five-Year Evaluation of an Anal Cancer Screening Program in Men Who Have Sex With Men With HIV at 2 Academic Center Clinics.Achhra AC, Chan E, Applebaum S, Guerrero M, Hao R, Pantel H, Virata M, Fikrig M, Barakat L. Clin Infect Dis. 2025 Jun 4. PMID: 39492696.
- Tumor microenvironment of non-small cell lung cancer impairs immune cell function among people with HIV.Desai SS, Salahuddin S, Yusuf R, Ranjan K, Gu J, Osmani L, Lin YE, Mehta S, Talmon R, Kang I, Kluger Y, Zhao H, Schalper KA, Emu B. J Clin Invest. 2025 Jun 3; 2025 Jun 3. PMID: 40459946.
- Resistance Analyses in Heavily Treatment-Experienced People With HIV Treated With the Novel HIV Capsid Inhibitor Lenacapavir After 2 Years.Margot NA, Jogiraju V, Pennetzdorfer N, Naik V, VanderVeen LA, Ling J, Singh R, Dvory-Sobol H, Ogbuagu O, Segal-Maurer S, Molina JM, Rhee MS, Callebaut C. J Infect Dis. 2025 Jun 2. PMID: 39873394.
- Oral pre-exposure prophylaxis (PrEP) receipt and persistence among opioid-dependent people who inject drugs initiating PrEP for HIV prevention.Khati A, Copenhaver M, Xu R, Altice FL, Wickersham JA, Gautam K, Paudel K, Shrestha R. J Subst Use Addict Treat. 2025 Jun; 2025 Apr 11. PMID: 40222706.
- Impact of multi-level factors and partner characteristics on antiretroviral therapy adherence and access to HIV care during the COVID-19 pandemic.Neuenschwander P, Norcini Pala A, Altice FL, Remien RH, Mergenova G, Rozental E, Gulyayev V, Davis A. Int J STD AIDS. 2025 Jun; 2025 Mar 28. PMID: 40155324.
- Predicting antiretroviral medication adherence among substance-using people with HIV: test and extension of the information-motivation-behavioral skills model.Krishnan A, Ranjit YS, Zhou X, Altice FL. J Behav Med. 2025 Jun; 2025 Feb 9. PMID: 39924604.
- Initiating Injectable Buprenorphine in People Hospitalized With Infections: A Randomized Clinical Trial.Seval N, Roth P, Frank CA, Di Paola A, Litwin AH, Vander Wyk B, Neirinckx V, Schlossberg E, Lawson P, Strong M, Schade MA, Nunez J, Levin FR, Brady KT, Nunes EV, Springer SA. JAMA Netw Open. 2025 May 1; 2025 May 1. PMID: 40445619.
- Novel Elective Course on Substance Use for Pharmacy Students in Jordan.Wazaify M, Al-Khateeb Y, Khoshnood K, Muvvala SB, Minahan-Rowley R, Abu-Dahab R, Tetrault JM. Am J Pharm Educ. 2025 May; 2025 Mar 28. PMID: 40158728.
- Exploring barriers and potential solutions before implementing a scale-up strategy to expand methadone coverage among people who inject drugs in Tajikistan.O'Hara GL, Madden LM, Burkhonov A, Alaei A, Mohsinzoda G, Bromberg DJ, Abdullozoda J, Yusufi SJ, Altice FL. J Subst Use Addict Treat. 2025 May; 2025 Mar 24. PMID: 40139416.
- Exploration of the multi-level barriers to scaling up methadone for HIV prevention among people who inject drugs in Kazakhstan.Liberman AR, Rozental Y, Ivasiy R, Kussainova AZ, Primbetova S, Madden LM, Terlikbayeva A, Altice FL. J Subst Use Addict Treat. 2025 May; 2025 Feb 20. PMID: 39986387.
- Efficacy, safety, and pharmacokinetics of lenacapavir oral bridging when subcutaneous lenacapavir cannot be administered.Ogbuagu OE, Avihingsanon A, Segal-Maurer S, Wang H, Jogiraju VK, Singh R, Rhee MS, Dvory-Sobol H, Sklar PA, Molina JM. AIDS. 2025 May 1; 2025 Feb 10. PMID: 39912752.
- Procedural Entrustment Alignment Between Pediatric Residents and Their Preceptors in the Pediatric Emergency Department.Goldman MP, Slade MD, Gielissen K, Hirsch AW, Prabhu EA, Dunne DW, Auerbach MA. Pediatr Emerg Care. 2025 May 1; 2025 Apr 30. PMID: 39841101.
- Exercise Interventions Conducted Among Individuals with Co-occurring HIV and Unhealthy Substance Use: A Systematic Review.Mistler CB, Allen W, Grimshaw AA, Idiong CI, Harsono D, Irwin ML, Ash G, S Pescatello L, Meyer JP, Jennifer Edelman E. AIDS Behav. 2025 Apr 28; 2025 Apr 28. PMID: 40289036.
- Pilot Findings From the First Legalized Mobile Retail Pharmacy Clinic in the United States for Infectious Disease Treatment and Prevention Tailored to Reach People Who Use Drugs.Tarfa A, Di Paola A, Frank CA, Schultheis AM, Brooks R, Shenoi SV, Springer SA. Open Forum Infect Dis. 2025 Apr; 2025 Apr 24. PMID: 40276721.
- Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People with HIV in Project CoRECT: A Mixed Methods Study.Macharaviani E, Altice FL, Shrestha R, Truebig J, Carroll C, Nichols L, Ahmad B, Copenhaver M, Villanueva M. AIDS Behav. 2025 Apr 10; 2025 Apr 10. PMID: 40205311.
- Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons.Kelley CF, Acevedo-Quiñones M, Agwu AL, Avihingsanon A, Benson P, Blumenthal J, Brinson C, Brites C, Cahn P, Cantos VD, Clark J, Clement M, Creticos C, Crofoot G, Diaz RS, Doblecki-Lewis S, Gallardo-Cartagena JA, Gaur A, Grinsztejn B, Hassler S, Hinojosa JC, Hodge T, Kaplan R, Lacerda M, LaMarca A, Losso MH, Valdez Madruga J, Mayer KH, Mills A, Mounzer K, Ndlovu N, Novak RM, Perez Rios A, Phanuphak N, Ramgopal M, Ruane PJ, Sánchez J, Santos B, Schine P, Schreibman T, Spencer LY, Van Gerwen OT, Vasconcelos R, Vasquez JG, Zwane Z, Cox S, Deaton C, Ebrahimi R, Wong P, Singh R, Brown LB, Carter CC, Das M, Baeten JM, Ogbuagu O. N Engl J Med. 2025 Apr 3; 2024 Nov 27. PMID: 39602624.
- Retention and dropout from sublingual and extended-release buprenorphine treatment: A comparative analysis of data from a nationally representative sample of commercially-insured people with opioid use disorder in the United States.Ivasiy R, Madden LM, Johnson KA, Machavariani E, Ahmad B, Oliveros D, Tan J, Kil N, Altice FL. Int J Drug Policy. 2025 Apr; 2025 Feb 27. PMID: 40020306.
- Proposed Framework for Setting Practical and Ethical Boundaries in Medicine.Hull SC, Angoff NR. JAMA Intern Med. 2025 Apr 1. PMID: 39899311.
- Drug interactions in people with HIV treated with antivirals for other viral illnesses.Okoli A, Ogbuagu O. Expert Opin Drug Metab Toxicol. 2025 Apr; 2025 Jan 23. PMID: 39836520.
- Impact of a Web-Based Curriculum on Internal Medicine Resident Use of Stigmatizing Language for Substance Use Disorder.Samberg D, Spinella S, Rothenberger S, Tetrault JM, Childers J. Subst Use Addctn J. 2025 Apr; 2024 Dec 17. PMID: 39690470.
- Using nominal group technique to identify and prioritize barriers to decentralizing HIV care to primary health centers in Lima, Peru.Oliveros D, Konda KA, Madden LM, Montenegro-Idrogo JJ, Tafur Quintanilla KT, Sosa Barbarán K, Nikitin BM, Ponticiello M, Benites CM, Sánchez J, Altice FL. BMC Health Serv Res. 2025 Mar 29; 2025 Mar 29. PMID: 40156011.
- Efficacy and Safety of Long-Acting Subcutaneous Lenacapavir in Heavily Treatment-Experienced People with Multidrug-Resistant HIV-1: Week 104 Results of a Phase 2/3 Trial.Ogbuagu O, Molina JM, Chetchotisakd P, Ramgopal MN, Sanchez W, Brunetta J, Castelli F, Crofoot GE, Hung CC, Ronot-Bregigeon S, Margot NA, Wang H, Dvory-Sobol H, Rhee MS, Segal-Maurer S. Clin Infect Dis. 2025 Mar 17. PMID: 39206943.
- Characterisation of a syndemic of STI symptoms, substance use and violence among incarcerated Peruvian women.Cyrus E, Turpin R, Dyer T, Hashemi E, Ali S, Bazo AC, Morgan-Lopez A, Scheidell JD, Leon SR, Sciaudone M, Altice FL. Sex Transm Infect. 2025 Mar 12; 2025 Mar 12. PMID: 40081910.
- Evaluating community knowledge of tuberculosis preventive therapy in rural South Africa.Foppiano Palacios C, Moll AP, Shrestha R, Kompala T, Davis JL, Charalambous S, Chimoyi L, Chihota V, Andrews L, Shenoi SV. BMC Public Health. 2025 Mar 7; 2025 Mar 7. PMID: 40055618.
- Prescribing methadone in prison predicts linkage to HIV care after release from prison: A randomized and patient preference trial.Mobley AM, Wegman MP, Bazazi AR, Shenoi SV, Bromberg DJ, Ahmad A, Kamarulzaman A, Altice FL. Int J Drug Policy. 2025 Mar; 2025 Feb 8. PMID: 39923270.
- Tuberculosis and people who use drugs: why focus on this overlooked population is important and why adapted interventions are necessary.D'Ottavi M, Godfrey-Faussett P, Merle CS, Sofonea MT, Laureillard D, Vickerman P, Molès JP, Altice FL, Van de Perre P, Stone J, Nagot N. Lancet Glob Health. 2025 Mar; 2025 Jan 22. PMID: 39862874.
- Transformation of the HIV treatment cascade for people who inject drugs in Ukraine.Bromberg DJ, Rhoades D, Madden LM, Ivasiy R, Meteliuk A, Pykalo I, Filippovych M, Nikitin BM, Farnum SO, Fomenko T, Dvoriak S, Altice FL. AIDS. 2025 Mar 1; 2024 Dec 13. PMID: 39589135.
- Longitudinal CNS and systemic T-lymphocyte and monocyte activation before and after antiretroviral therapy beginning in primary HIV infection.Chan P, Li X, Li F, Emu B, Price RW, Spudich S. Front Immunol. 2025; 2025 Feb 25. PMID: 40070827.
- Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.Gandhi RT, Landovitz RJ, Sax PE, Smith DM, Springer SA, Günthard HF, Thompson MA, Bedimo RJ, Benson CA, Buchbinder SP, Crabtree-Ramirez BE, Del Rio C, Eaton EF, Eron JJ Jr, Hoy JF, Lehmann C, Molina JM, Jacobsen DM, Saag MS. JAMA. 2025 Feb 18. PMID: 39616604.
- Real-world Rollout of Injectable Antiretrovirals for HIV Prevention and Treatment: Correlates of Early Adoption.Koshy L, Payne E, Barakat L, Hao R, Sureshanand S, Cedillo Ornelas A, Dewan A, Meyer JP. Open Forum Infect Dis. 2025 Feb; 2025 Jan 20. PMID: 40207202.
- Decarceration and COVID-19 infections in U.S. Immigration and Customs Enforcement detention facilities: a simulation modeling study.Weyant C, Meyer JP, Bromberg D, Beyrer C, Altice FL, Goldhaber-Fiebert JD. Lancet Reg Health Am. 2025 Feb; 2024 Dec 27. PMID: 39830893.
- Decrease in provider stigma is associated with improved quality health indicators among individuals receiving methadone in primary care centers in Ukraine.Machavariani E, Bromberg DJ, Dumchev K, Esserman D, Earnshaw VA, Pykalo I, Filippovich M, Ivasiy R, Ahmad B, Long J, Haddad MS, Madden LM, Oliveros D, Dvoriak S, Altice FL. Int J Drug Policy. 2025 Feb; 2024 Dec 19. PMID: 39705875.
- The Feasibility and Acceptability of a Clinical Pharmacist-delivered Intervention to Reduce Bothersome Health Symptoms from Polypharmacy and Alcohol Use and Communicate Risk among People with HIV: Pilot Study Protocol.Womack JA, Leblanc MM, Sager AS, Zaets LN, Maisto SA, Garcia A, Aoun-Barakat L, Brown SE, Edelman EJ, Fiellin DA, Fisher J, Fraenkel L, Kidwai-Khan F, Marconi VC, Martino S, Pulk R, Satre DD, Virata M, Justice AC, Hsieh E. AIDS Behav. 2025 Feb; 2024 Oct 28. PMID: 39465468.
- Rationale and design of a randomized clinical trial of integrated eHealth for PrEP and medications for opioid use disorders for women in the criminal legal system. The Athena study.Meyer JP, Brunson S, Price CR, Mulrain M, Nguyen J, Altice FL, Kyriakides TC, Cropsey K, Eaton E. Addict Sci Clin Pract. 2025 Jan 17; 2025 Jan 17. PMID: 39825419.
- "Men Take Care of Each Other": Evaluation of a Community-Based Model for Pre-exposure Prophylaxis Services Among Male Bar Patrons in Rural South Africa.Chen P, Nkosi S, Moll AP, Braithwaite RS, Ngubane SG, Shenoi SV. AIDS Patient Care STDS. 2025 Jan; 2025 Jan 6. PMID: 39761130.
- Improving implementation of needle and syringe programmes to expand, scale up, and sustain evidence-based prevention interventions for HIV and hepatitis C in prisons.Kronfli N, Bromberg DJ, Wolff H, Montanari L, Vasyliev S, Altice FL. Lancet Public Health. 2025 Jan; 2024 Dec 16. PMID: 39701113.
- Commentary on Gregory et al.: Fear of precipitated opioid withdrawal should not prevent buprenorphine initiation.Springer SA. Addiction. 2025 Jan; 2024 Nov 4. PMID: 39494653.
- A qualitative dyad analysis of barriers and facilitators of antiretroviral therapy (ART) adherence among people who inject drugs (PWID) with HIV in Kazakhstan.Neuenschwander P, Altice FL, Remien RH, Mergenova G, Sarsembayeva L, Rozental E, Gulyayev V, Davis A. AIDS Care. 2025 Jan; 2024 Oct 15. PMID: 39404196.
- Transition to Enteral Triazole Antifungal Therapy for Pediatric Invasive Candidiasis: Secondary Analysis of a Multicenter Cohort Study Conducted by the Pediatric Fungal Network.Bucayu RFT, Boge CLK, Yildirim I, Avilés-Robles M, Vora SB, Berman DM, Sharma TS, Sung L, Castagnola E, Palazzi DL, Danziger-Isakov L, Yin DE, Roilides E, Maron G, Tribble AC, Soler-Palacin P, López-Medina E, Romero J, Belani K, Arrieta AC, Carlesse F, Nolt D, Halasa N, Dulek D, Rajan S, Muller WJ, Ardura MI, Pong A, Gonzalez BE, Salvatore CM, Huppler AR, Aftandilian C, Abzug MJ, Chakrabarti A, Green M, Lutsar I, Knackstedt ED, Johnson SK, Steinbach WJ, Fisher BT, Wattier RL. J Pediatric Infect Dis Soc. 2024 Dec 30. PMID: 39513400.
- Disruptions to HIV Prevention During Armed Conflict in Ukraine and Other Settings.Nikitin BM, Bromberg DJ, Ivasiy R, Madden L, Machavariani E, Dvoriak S, Poole DN, Otiashvilli D, Altice FL. Curr HIV/AIDS Rep. 2024 Dec 14; 2024 Dec 14. PMID: 39672977.
- Plans to end HIV should address substance use.Springer SA. Lancet HIV. 2024 Dec. PMID: 39632048.
- Continuous care engagement in clinical practice: perspectives on selected current strategies for people with HIV in the United States.Villanueva MS, Wheeler DP, Applin S, Hodge TW, Zack B, Rebeiro PF. Expert Rev Anti Infect Ther. 2024 Dec; 2024 Oct 17. PMID: 39417530.
- Comparing the brief Holistic Health for HIV (3H+) to the Holistic Health Recovery Program (HHRP+) among people with HIV and opioid use disorder: Results from a randomized, controlled non-inferiority trial.Zelenev A, Huedo-Medina TB, Shrestha R, Mistler CB, Altice FL, Sibilio B, Copenhaver MM. PLoS One. 2024; 2024 Nov 7. PMID: 39509356.
- A Randomized Placebo-Controlled Trial of Leronlimab in Mild-To-Moderate COVID-19.Seethamraju H, Yang OO, Loftus R, Ogbuagu O, Sammartino D, Mansour A, Sacha JB, Ojha S, Hansen SG, Arman AC, Lalezari JP. Clin Ther. 2024 Nov; 2024 Sep 30. PMID: 39353749.
- Design and implementation of a Type-2 hybrid, prospective randomized trial of opioid agonist therapies integration into primary care clinics in Ukraine.Machavariani E, Dumchev K, Pykalo I, Filippovych M, Ivasiy R, Esserman D, Madden LM, Bromberg DJ, Haddad M, Morozova O, Ahmad B, Gómez DO, Farnum SO, Dvoriak S, Altice FL. Contemp Clin Trials. 2024 Nov; 2024 Sep 14. PMID: 39265780.
- User preferences for an mHealth app to support HIV testing and pre-exposure prophylaxis uptake among men who have sex with men in Malaysia.Palmer L, Wickersham JA, Gautam K, Maviglia F, Bruno BD, Azwa I, Khati A, Altice FL, Paudel K, Pagoto S, Shrestha R. PLOS Digit Health. 2024 Oct; 2024 Oct 30. PMID: 39475851.
- Integrated Online-to-Offline Model of Care for HIV Prevention and Treatment Among Men Who Have Sex With Men in Malaysia: Protocol for an Intervention Development and a Multiphase Trial.Khati A, Wickersham JA, Gautam K, Paudel K, Phiphatkhunarnon P, Lim SH, Puniamurthy K, Altice FL, Phanuphak N, Azwa I, Shrestha R. JMIR Res Protoc. 2024 Oct 23; 2024 Oct 23. PMID: 39441624.
- To Be: Where Belonging Starts.Barakat LA, Genao I. J Gen Intern Med. 2024 Oct 22; 2024 Oct 22. PMID: 39438383.
- Burden of tuberculosis in underserved populations in South Africa: A systematic review and meta-analysis.Holtgrewe LML, Johnson A, Nyhan K, Boffa J, Shenoi SV, Karat AS, Davis JL, Charalambous S. PLOS Glob Public Health. 2024; 2024 Oct 3. PMID: 39361564.
- Analysis of drug-drug interactions in patients with HIV and metabolic syndrome.Tuan J, Igiraneza G, Ogbuagu O. Expert Opin Drug Metab Toxicol. 2024 Oct; 2024 Sep 10. PMID: 39230187.
- The cascade of care for commercially-insured persons with opioid use disorder and comorbid HIV and HCV infections.Ivasiy R, Madden LM, DiDomizio E, Johnson KA, Machavariani E, Ahmad B, Oliveros D, Ram A, Kil N, Altice FL. Drug Alcohol Depend. 2024 Oct 1; 2024 Aug 12. PMID: 39159600.
- A PrEP decision aid for women survivors of intimate partner violence: Task-shifting implementation to domestic violence service settings.Meyer JP, Lazarus E, Phillips K, Watts ZT, Duroseau B, Carlson C, Price CR, Kershaw T, Willie TC. PLoS One. 2024; 2024 Sep 17. PMID: 39288155.
- Underuse of Lifesaving Medications for Opioid Use Disorder in US Jails.Springer SA. JAMA Netw Open. 2024 Sep 3; 2024 Sep 3. PMID: 39316405.
- Revisiting Preaddiction.Miller SC, Levy S, Saxon AJ, Tetrault JM, Rosenthal RN, Wakeman S, Vocci F. J Addict Med. 2024 Sep-Oct 01; 2024 Aug 10. PMID: 39356619.
- Interventions to reduce harms related to drug use among people who experience incarceration: systematic review and meta-analysis.Macdonald C, Macpherson G, Leppan O, Tran LT, Cunningham EB, Hajarizadeh B, Grebely J, Farrell M, Altice FL, Degenhardt L. Lancet Public Health. 2024 Sep. PMID: 39214637.
- Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake.Lafferty L, Altice FL, Leone F, Stoové M, Lloyd AR, Hajarizadeh B, Kronfli N. Int J Drug Policy. 2024 Sep; 2024 Aug 13. PMID: 39141957.
- HIV and Substance Use Disorders.Lier AJ, Tarfa A, Shenoi SV, Kuo I, Springer SA. Infect Dis Clin North Am. 2024 Sep; 2024 Jul 2. PMID: 38960783.
- The impact of emergency guidance to the COVID-19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine.Ivasiy R, Madden LM, Meteliuk A, Machavariani E, Ahmad B, Zelenev A, Desai MM, Bromberg DJ, Polonsky M, Galvez de Leon SJ, Farnum SO, Islam Z, Altice FL. Addiction. 2024 Sep; 2024 May 28. PMID: 38807448.
- Perspectives on benefits and risks of creation of an "injection drug use" billing code.Sundaram G, Sato T, Goodman-Meza D, Haddad M, Thakarar K, Feinberg J, Springer SA, Barton K, Butler N, Eaton EF, Wurcel AG. J Subst Use Addict Treat. 2024 Sep; 2024 May 10. PMID: 38735482.
- Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthcare workers.Kronfli N, Lafferty L, Leone F, Stoové M, Hajarizadeh B, Lloyd AR, Altice FL. Int J Drug Policy. 2024 Aug; 2024 Jul 29. PMID: 39079352.
- Influence of Stigma on Engagement in HIV Care and Adherence to Antiretroviral Therapy in Specialized HIV Clinics Targeting Men Who Have Sex with Men and Transgender Women in Lima, Peru.Oliveros Gómez D, Machavariani E, Altice FL, Gálvez de León S, Earnshaw V, Montenegro-Idrogo JJ, Sánchez J, Seminario AL. AIDS Behav. 2024 Aug; 2024 Jun 15. PMID: 38878137.
- HIV Activist Identity, Commitment, and Orientation Scale (HAICOS): Psychometric Evaluation to Assess Clinician's Propensity Towards HIV Activism in Malaysia.Chong N, Azwa I, Hassan AA, Mousavi ME, Wong PL, Ng RX, Saifi R, Basri S, Omar SFS, Walters SM, Collier ZK, Haddad MS, Altice FL, Kamarulzaman A, Earnshaw VA. AIDS Behav. 2024 Aug; 2024 May 28. PMID: 38806844.
- High rates of deferring antiretroviral treatment for patients with HIV and substance use disorders: Results from a national sample of HIV physicians in Ukraine.Ottesen TD, Wickersham JA, Lawrence JC, Antoniak S, Zezuilin O, Polonsky M, Antonyak S, Rozanova J, Dvoriak S, Pykalo I, Filippovych M, Altice FL. PLoS One. 2024; 2024 Jul 19. PMID: 39028735.
- Missed Opportunities for Preexposure Prophylaxis Initiation in Hospitalized Persons With Opioid Use Disorder and Infectious Diseases.Parchinski K, Neirinckx V, Frank C, Di Paola A, Tarfa A, Shenoi S, Vander Wyk B, Roth P, Ghantous T, Wegman MK, Strong M, Levin FR, Brady K, Nunes E, Litwin AH, Springer SA. Open Forum Infect Dis. 2024 Jul; 2024 Jul 10. PMID: 39022389.
- Serious Opioid Injection-Related Infection and Initiation of Medication for Opioid Use Disorder.Springer SA. JAMA Netw Open. 2024 Jul 1; 2024 Jul 1. PMID: 39046746.
- Considerations when prescribing opioid agonist therapies for people living with HIV.Tarfa A, Lier AJ, Shenoi SV, Springer SA. Expert Rev Clin Pharmacol. 2024 Jul; 2024 Jul 4. PMID: 38946101.
- Nonmedical Use of Stimulants Among Students in Jordan: A Nationwide Study.Abdulfattah S, Ahmad AR, Kitaneh R, Alsharaydeh T, Almudallal F, Alzoubi R, Abbadi R, Haddad TA, Wazaify M, Alkayed Z, Bani Mustafa R, Tetrault JM. J Addict Med. 2024 Jul-Aug 01; 2024 Apr 6. PMID: 38587298.
- Shared Medical Appointment: A Novel Model for Incorporating Group Visits Into Residency Training for Substance Use Disorders.Cavallo DA, Salwan JK, Doernberg M, Tetrault JM, Holt SR. Subst Use Addctn J. 2024 Jul; 2024 Mar 17. PMID: 38494709.
- Preparing Physicians to Treat Addiction: Inclusion of Dedicated Addiction Training During Internal Medicine Residency.Canver B, Liptak A, Clark K, Tetrault JM, Holt SR. Subst Use Addctn J. 2024 Jul; 2024 Jan 22. PMID: 38254274.
- Hepatitis C virus and integrated care for substance use disorders.Mahoney BJ, Morford KL, Biegacki ET, Tetrault JM. Clin Liver Dis (Hoboken). 2024 Jan-Jun; 2024 Jun 28. PMID: 38952692.
- Alcohol Use Disorder and HIV Risk in a National Survey of Men Who Have Sex with Men in Ukraine.Gabriel W, Sazonova Y, Kulchynska R, LaMonaca K, Salyuk T, Smyrnov P, Altice FL. Int J Behav Med. 2024 Jun 24; 2024 Jun 24. PMID: 38914921.
- Projected environmental and public health benefits of extended-interval dosing: an analysis of pembrolizumab use in a US national health system.Bryant AK, Lewy JR, Bressler RD, Chopra Z, Gyori DJ, Bazzell BG, Moeller JA, Jacobson SI, Fendrick AM, Kerr EA, Ramnath N, Green MD, Hofer TP, Vaishnav P, Strohbehn GW. Lancet Oncol. 2024 Jun. PMID: 38821085.
- The MATE Act: Progress for substance use education, but is checking a box enough?Morford KL, Tetrault JM, Fiellin DA. J Gen Intern Med. 2024 Jun; 2024 Feb 2. PMID: 38308156.
- Human costs of healthcare resilience during the war in Ukraine: Lessons from addiction and HIV treatment.Rozanova J, Zaviryukha I, Deac AA, Zeziulin O, Kiriazova T, Earnshaw V, Rich KM, Shenoi SV, Skipper H, Yariy V, Strang SJ. Addiction. 2024 Jun; 2023 Dec 21. PMID: 38130082.
- Impact of COVID-19 on women living with HIV who are survivors of intimate partner violence.Zhang X, Price CR, Pope AS, Sullivan TP, Meyer JP. BMC Public Health. 2024 May 20; 2024 May 20. PMID: 38769576.
- National HIV and HCV Screening Rates for Hospitalized People who Use Drugs Are Suboptimal and Heterogeneous Across 11 US Hospitals.Westgard LK, Sato T, Bradford WS, Eaton EF, Pilcher F, Hale AJ, Singh D, Martin M, Appa AA, Meyer JP, Weimer MB, Barakat LA, Felsen UR, Akiyama MJ, Ridgway JP, Grussing ED, Thakarar K, White A, Mutelayi J, Krsak M, Montague BT, Nijhawan A, Balakrishnan H, Marks LR, Wurcel AG. Open Forum Infect Dis. 2024 May; 2024 Apr 16. PMID: 38746950.
- Ukrainian healthcare providers under siege during the first year of war: challenges and adaptations.Deac AA, Zaviryukha I, Zeziulin O, Peycheva A, Solórzano de Souza R, Skipper H, Abubakar A, Gustilo VB, Shenoi SV, Thornicroft G, Rozanova J. BJPsych Int. 2024 May. PMID: 38693956.
- Using Data-To-Care Strategies to Optimize the HIV Care Continuum in Connecticut: Results From a Randomized Controlled Trial.Machavariani E, Miceli J, Altice FL, Fanfair RN, Speers S, Nichols L, Jenkins H, Villanueva M. J Acquir Immune Defic Syndr. 2024 May 1. PMID: 38324241.
- Prevalence and Correlates of Physical Inactivity Among Individuals with HIV During the First COVID-19 Wave: A Cross-sectional Survey.Harsono D, Deng Y, Chung S, Barakat LA, Friedland G, Villanueva M, Yager JE, Justen M, Edelman EJ. AIDS Behav. 2024 May; 2023 Oct 12. PMID: 37824037.
- HIV-1-infected T cell clones are shared across cerebrospinal fluid and blood during ART.Wang M, Yoon J, Reisert H, Das B, Orlinick B, Chiarella J, Halvas EK, Mellors J, Pang AP, Barakat LA, Fikrig M, Cyktor J, Kluger Y, Spudich S, Corley MJ, Farhadian SF. JCI Insight. 2024 Apr 8; 2024 Apr 8. PMID: 38587074.
- Higher methadone dose at time of release from prison predicts linkage to maintenance treatment for people with HIV and opioid use disorder transitioning to the community in Malaysia.Ahmad A, Bromberg DJ, Shrestha R, Salleh NM, Bazazi AR, Kamarulzaman A, Shenoi S, Altice FL. Int J Drug Policy. 2024 Apr; 2024 Mar 14. PMID: 38484531.
- Sustained mental health and functional responses to the COVID-19 pandemic in Black and White Veterans with psychosis or recent homelessness.Novacek DM, Wynn JK, McCleery A, Reavis EA, Senturk D, Sugar CA, Tsai J, Green MF. J Psychiatr Res. 2024 Apr; 2024 Feb 15. PMID: 38373371.
- Misogynistic Extremism: A Scoping Review.O'Hanlon R, Altice FL, Lee RK, LaViolette J, Mark G, Papakyriakopoulos O, Saha K, De Choudhury M, Kumar N. Trauma Violence Abuse. 2024 Apr; 2023 Jun 5. PMID: 37272372.
- Lemierre syndrome with pulmonary empyema caused by Prevotella intermedia.Simsek B, Zhang R, Morton C, Villanueva MS. BMJ Case Rep. 2024 Mar 15; 2024 Mar 15. PMID: 38490705.
- Implementation of REDCap mobile app in an oral HIV clinical study.Seminario AL, Karczewski AE, Stanley S, Huamani JV, Montenegro JJ, Tafur K, Julca AB, Altice FL. BMC Public Health. 2024 Feb 28; 2024 Feb 28. PMID: 38413910.
- Efficacy and Impact of Peer-Led Education for Persons with Tuberculosis in Kampala, Uganda: A Pre-Post Implementation Study.Baker A, Gupta AJ, Nanziri L, Ggita JM, Hernandez-Ramirez RU, Shenoi SV, Ayakaka I, Armstrong-Hough M, Katamba A, Davis JL. Res Sq. 2024 Feb 16; 2024 Feb 16. PMID: 38410451.
- Implementation of Chatbot Technology in Health Care: Protocol for a Bibliometric Analysis.Ni Z, Peng ML, Balakrishnan V, Tee V, Azwa I, Saifi R, Nelson LE, Vlahov D, Altice FL. JMIR Res Protoc. 2024 Feb 15; 2024 Feb 15. PMID: 38228575.
- Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowledge.Bromberg DJ, Machavariani E, Madden LM, Dumchev K, LaMonaca K, Earnshaw VA, Pykalo I, Filippovych M, Haddad MS, Dvoriak S, Altice FL. J Int AIDS Soc. 2024 Feb. PMID: 38379179.
- Preferences and decisional considerations relating to opioid agonist therapy among Ukrainian people who use drugs: A conjoint analysis survey.Bromberg DJ, Madden LM, Fraenkel L, Muthulingam D, Rhoades D, Dvoriak S, Dumchev K, Pykalo I, Altice FL. PLOS Glob Public Health. 2024; 2024 Jan 26. PMID: 38277422.
- Testing the Feasibility and Acceptability of Using an Artificial Intelligence Chatbot to Promote HIV Testing and Pre-Exposure Prophylaxis in Malaysia: Mixed Methods Study.Cheah MH, Gan YN, Altice FL, Wickersham JA, Shrestha R, Salleh NAM, Ng KS, Azwa I, Balakrishnan V, Kamarulzaman A, Ni Z. JMIR Hum Factors. 2024 Jan 26; 2024 Jan 26. PMID: 38277206.
- Corrigendum: High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine.Galvez SJ, Altice FL, Meteliuk A, Ivasiy R, Machavariani E, Farnum SO, Fomenko T, Islam Z, Madden LM. Front Public Health. 2023; 2024 Jan 11. PMID: 38274528.
- Trajectory and progress of opioid agonist therapy programs in the Kyrgyz Republic.Liberman AR, Kurmanalieva A, Biibosunova DI, Shumskaya N, Ivasiy R, Bromberg DJ, Madden LM, Altice FL. Glob Health Econ Sustain. 2024; 2024 Sep 26. PMID: 40212662.